RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer.
Dustin D, Gu G, Beyer AR, Herzog SK, Edwards DG, Lin H, Gonzalez TL, Grimm SL, Coarfa C, Chan DW, Kim BJ, De La O JP, Ellis MJ, Liu D, Li S, Welm AL, Fuqua SAW.
Dustin D, et al. Among authors: de la o jp.
Br J Cancer. 2021 Jan;124(1):191-206. doi: 10.1038/s41416-020-01174-z. Epub 2020 Dec 1.
Br J Cancer. 2021.
PMID: 33257837
Free PMC article.